At KAICO, we use the "silkworm-baculovirus expression system" as our core technology, which is based on the use of the Kyushu University's proprietary baculovirus genome and expertise in gene and protein design. This allows us to express target proteins within the silkworm's body.
Utilizing highly productive silkworm strains uniquely possessed by Kyushu University, and our proprietary gene design expertise, our recombinant protein production platform can produce high-quality proteins that are difficult to produce in other expression systems.